Patents by Inventor Richard Benjamin POUW

Richard Benjamin POUW has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240336676
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: October 16, 2023
    Publication date: October 10, 2024
    Inventors: Scott Lauder, Tom Purcell, Sridhar Govindarajan, Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw, Taede Rispens, Ilse Jongerius, Gillian Dekkers
  • Patent number: 11820814
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Grant
    Filed: July 17, 2020
    Date of Patent: November 21, 2023
    Assignees: GEMINI THERAPEUTICS SUB, INC., STICHTING SANQUIN BLOEDVOORZIENING
    Inventors: Scott Lauder, Tom Purcell, Sridhar Govindarajan, Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw, Taede Rispens, Ilse Jongerius, Gillian Dekkers
  • Publication number: 20220372120
    Abstract: Provided herein are novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H, or nucleic acids or vectors encoding such antibodies and fragments. Further provided herein is the use of such antibodies, fragments, nucleic acids or vectors for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: July 17, 2020
    Publication date: November 24, 2022
    Inventors: Scott LAUDER, Tom PURCELL, Sridhar GOVINDARAJAN, Taco Willem KUIJPERS, Diana WOUTERS, Maria Clara BROUWER, Richard Benjamin POUW, Taede RISPENS, Ilse JONGERIUS, Gillian DEKKERS
  • Publication number: 20220356235
    Abstract: The invention relates to novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: June 1, 2022
    Publication date: November 10, 2022
    Inventors: Taco Willem KUIJPERS, Diana WOUTERS, Maria Clara BROUWER, Richard Benjamin POUW
  • Patent number: 11377487
    Abstract: The invention relates to novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Grant
    Filed: January 15, 2019
    Date of Patent: July 5, 2022
    Assignee: Stichting Sanquin Bloedvoorziening
    Inventors: Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw
  • Publication number: 20210054059
    Abstract: The invention relates to novel isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: January 15, 2019
    Publication date: February 25, 2021
    Inventors: Taco Willem KUIJPERS, Diana WOUTERS, Maria Clara BROUWER, Richard Benjamin POUW
  • Publication number: 20190194304
    Abstract: The invention relates to isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: October 29, 2018
    Publication date: June 27, 2019
    Inventors: Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw
  • Patent number: 10112993
    Abstract: The invention relates to isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Grant
    Filed: August 20, 2015
    Date of Patent: October 30, 2018
    Assignee: STICHTING SANQUIN BLOEDVOORZIENING
    Inventors: Taco Willem Kuijpers, Diana Wouters, Maria Clara Brouwer, Richard Benjamin Pouw
  • Publication number: 20170355753
    Abstract: The invention relates to isolated, synthetic or recombinant antibodies and fragments thereof specific for factor H. The invention further relates to the use of such antibodies and fragments for inhibiting complement activation and treatment of disorders associated with complement activation.
    Type: Application
    Filed: August 20, 2015
    Publication date: December 14, 2017
    Inventors: Taco Willem KUIJPERS, Diana WOUTERS, Maria Clara BROUWER, Richard Benjamin POUW